Sonoma Pharmaceuticals, Inc. Common Stock Shares Outstanding

• Sonoma Pharmaceuticals, Inc. showed an increase of +54.4% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
• XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2011 to 2025), Sonoma Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has declined by 93.9%.
• Historical annual values: Fiscal year 2025: 1.63 million shares | Fiscal year 2024: 1.06 million shares | Fiscal year 2024: 780,371 shares | Fiscal year 2023: 4.93 million shares | Fiscal year 2022: 3.10 million shares | Fiscal year 2021: 2.09 million shares | Fiscal year 2020: 1.78 million shares | Fiscal year 2019: 1.33 million shares | Fiscal year 2019: 1.32 million shares | Fiscal year 2018: 685,747 shares | Fiscal year 2017: 4.29 million shares | Fiscal year 2016: 4.20 million shares | Fiscal year 2015: 15.05 million shares | Fiscal year 2014: 8.16 million shares | Fiscal year 2013: 6.58 million shares | Fiscal year 2012: 4.14 million shares | Fiscal year 2011: 26.58 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026